Pyxis Oncology: Better Runway Is Bullish For MICVO’s Remaining R&D (NASDAQ:PYXS)
· seekingalpha.com
Pyxis Oncology update: The MICVO oncology drug shows promising early data; dosage optimization is ahead. Click for more on PYXS stock.
My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, ...